Transcode Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $753 | $0 |
Gross Profit | -142 | -141 | |
EBITDA | -5,043 | -3,175 | |
EBIT | -5,186 | -3,317 | |
Net Income | -5,190 | -3,326 | -4,087 |
Net Change In Cash | 0 | 753 | 0 |
Free Cash Flow | -2,344 | -3,941 | -5,663 |
Cash | 3,354 | 4,913 | 2,767 |
Basic Shares | 7,051 | 5,142 | 627 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -516 | -98 | -42 | |
EBITDA | -17,973 | -17,466 | -6,108 | -726 |
EBIT | -18,490 | -17,564 | -6,151 | -1,453 |
Net Income | -18,546 | -35,129 | -6,938 | -2,738 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -18,110 | -15,863 | -5,521 | -492 |
Cash | 2,767 | 4,968 | 20,825 | 828 |
Basic Shares | 179 | 16 | 16 | 7 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$5.28 |
2024-06-30 | -$976.80 |
2024-03-31 | -$22.84 |
2023-12-31 | -$627.33 |
